These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17117100)

  • 21. Botulinum toxin a in the treatment of blepharospasm: a 10-year experience.
    Silveira-Moriyama L; Gonçalves LR; Chien HF; Barbosa ER
    Arq Neuropsiquiatr; 2005 Jun; 63(2A):221-4. PubMed ID: 16100966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm.
    Truong DD; Gollomp SM; Jankovic J; LeWitt PA; Marx M; Hanschmann A; Fernandez HH;
    J Neural Transm (Vienna); 2013 Sep; 120(9):1345-53. PubMed ID: 23435927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm.
    Nüssgens Z; Roggenkämper P
    Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):197-9. PubMed ID: 9143885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A injection for the treatment of frown lines.
    Song KH
    Ann Pharmacother; 1998 Dec; 32(12):1365-7. PubMed ID: 9876820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Safety and Efficacy of Botox and Neuronox in the Management of Benign Essential Blepharospasm: A Split-face Study.
    Sane S; Ali MJ; Naik MN
    Korean J Ophthalmol; 2019 Oct; 33(5):430-435. PubMed ID: 31612653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
    Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
    Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin type B: pH change reduces injection pain, retains efficacy.
    Lowe PL; Lowe NJ
    Dermatol Surg; 2014 Dec; 40(12):1328-33. PubMed ID: 25350125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy.
    Lungu C; Considine E; Zahir S; Ponsati B; Arrastia S; Hallett M
    Eur J Neurol; 2013 Mar; 20(3):515-518. PubMed ID: 23146065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.
    Horwath-Winter J; Bergloeff J; Floegel I; Haller-Schober EM; Schmut O
    Br J Ophthalmol; 2003 Jan; 87(1):54-6. PubMed ID: 12488263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oculinum injection-resistant blepharospasm in young patients.
    Roggenkämper P; Nüssgens Z
    Ophthalmic Plast Reconstr Surg; 1997 Mar; 13(1):73. PubMed ID: 9076788
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of pain scores with 30-gauge and 32-gauge needles for periocular botulinum toxin type a injections.
    Yomtoob DE; Dewan MA; Lee MS; Harrison AR
    Ophthalmic Plast Reconstr Surg; 2009; 25(5):376-7. PubMed ID: 19966651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of topical anesthetics on needle insertion pain during botulinum toxin type A injections for limb spasticity.
    Fung S; Phadke CP; Kam A; Ismail F; Boulias C
    Arch Phys Med Rehabil; 2012 Sep; 93(9):1643-7. PubMed ID: 22449552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection.
    Kocabeyoglu S; Sekeroglu HT; Mocan MC; Muz E; Irkec M; Sanac AS
    Eur J Ophthalmol; 2014; 24(6):830-4. PubMed ID: 24803156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
    Gottsch HP; Yang CC; Berger RE
    Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-center, double-blind, randomized study to evaluate the efficacy of 4% lidocaine cream versus vehicle cream during botulinum toxin type A treatments.
    Carruthers A; Carruthers J
    Dermatol Surg; 2005 Dec; 31(12):1655-9. PubMed ID: 16336883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial.
    Colakoglu BD; Cakmur R; Uzunel F
    Eur Neurol; 2011; 65(5):286-90. PubMed ID: 21502764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.
    Gassner HG; Sherris DA
    Mayo Clin Proc; 2000 Jul; 75(7):701-4. PubMed ID: 10907385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum Toxin type A injections for patients with painful hallux valgus: a double-blind, randomized controlled study.
    Wu KP; Chen CK; Lin SC; Pei YC; Lin RH; Tsai WC; Fuk-Tan Tang S
    Clin Neurol Neurosurg; 2015 Feb; 129 Suppl 1():S58-62. PubMed ID: 25683315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.